Thalys Medical Technology Group Corporation (SHA:603716)

China flag China · Delayed Price · Currency is CNY
21.06
+0.15 (0.72%)
Apr 29, 2026, 3:00 PM CST
125.24%
Market Cap 4.48B
Revenue (ttm) 971.32M
Net Income (ttm) -210.48M
Shares Out 214.11M
EPS (ttm) -1.04
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 7,356,810
Average Volume 20,585,323
Open 20.52
Previous Close 20.91
Day's Range 20.35 - 21.25
52-Week Range 9.33 - 38.12
Beta 0.69
RSI 39.93
Earnings Date Apr 29, 2026

About SHA:603716

Thalys Medical Technology Group Corporation provides medical integrated operation and management services in China. It offers automated immunofluorescence analyzer; coagulation reagent; COVID-19 test kit; line blot1 fully automated immunoblotting instrument; and flow products. The company also provides automated coagulation analyzer; automated immunoassay system; automated biochemical analysis system; automated chemiluminescence immunoassay system; and blood analyzer. The company was formerly known as Thalys Medical Technology Inc. and changed ... [Read more]

Sector Healthcare
Founded 2004
Employees 1,246
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603716
Full Company Profile

Financial Performance

In 2025, SHA:603716's revenue was 1.08 billion, a decrease of -40.52% compared to the previous year's 1.81 billion. Losses were -207.28 million, -0.93% less than in 2024.

Financial Statements

News

There is no news available yet.